{"public_id":"cl_1a3bca2341d55c04de95b1f5b45d6840","status":"active","superseded_by_public_id":null,"corpus_id":216417969,"text":"Firibastat was clinically and biologically well tolerated, even at high doses, in phase I trials in healthy human subjects.","confidence":0.96,"paper":{"corpus_id":216417969,"title":"Targeting Brain Aminopeptidase A: A New Strategy for the Treatment of Hypertension and Heart Failure.","url":"https://sah.borca.ai/papers/216417969"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.96,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_305e0079561d257b1b631b0015688ea0","name":"firibastat","description":"An orally administered prodrug that crosses the blood-brain barrier and is converted to the APA inhibitor EC33.","types":["drug","prodrug"],"url":"https://sah.borca.ai/concepts/co_305e0079561d257b1b631b0015688ea0"},{"public_id":"co_8fc9a9faedca88adb055f342694ef406","name":"healthy human subjects","description":"People without the target disease enrolled for early safety assessment.","types":["study population"],"url":"https://sah.borca.ai/concepts/co_8fc9a9faedca88adb055f342694ef406"},{"public_id":"co_9746cbbb2705ef23b73dc39b41ab5def","name":"phase I trials","description":"Early clinical trials evaluating safety and tolerability in human subjects.","types":["clinical trial phase"],"url":"https://sah.borca.ai/concepts/co_9746cbbb2705ef23b73dc39b41ab5def"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_1a3bca2341d55c04de95b1f5b45d6840"}